Abstract:Objective: To investigate whether it is feasible to use the chondrogenic microenvironment provided by cartilage cells to construct cartilage tissues in vitro with bone marrow stromal cells (BMSC). Materials and Methods: We isolated and cultured BMSC and cartilage cells from Sprague Dawley rats (SD rats). The supernatant of cartilage culture was used as inducing solution to cause differentiation of BMSC from the second generation of cells cultured in vitro. Cells were examined seven days later, using immunohistochemistry to determine the expression of collagen specific to type II cartilage. RT-PCR was used to detect the expression of type II collagen and aggrecan mRNA. BMSC and cartilage cells were isolated from SD rats and cultured in vitro. The BMSC and cartilage cells in culture were mixed evenly in an 8:2 ratio and inoculated into a polyglycolic acid/polylactic acid (PGA/PLA) scaffold to a final concentration of 5.0x107 cells/ml. PGA/PLA preparations with pure cartilage cells or pure BMSC served as the positive and negative controls, respectively. The control group of low-concentration cartilage cells consisted of PGA/PLA preparations containing cartilage cells at 20% of the abovementioned concentration (1.0x107 cells/ml). Samples were collected eight weeks later, at which time general observations, wet weight, and glycosaminoglycan (GAG) levels were determined, and histological and immunohistochemical examinations were performed. Results: Immunohistochemistry showed the induction of BMSC type II collagen, and RT-PCR indicated the expression of type II collagen and aggrecan mRNA. In the mixed-cell group and the positive control group, pure mature cartilage cells were produced after eight weeks of culture in vitro, and the size and shape of the scaffold were maintained throughout the culture period. The two groups gave rise to newly generated cartilage cells essentially identical in appearance and histological properties. The immunohistochemical results showed that the cartilage cells of both groups expressed abundant cartilage-specific type II collagen. The average wet weight and GAG content were more than 70% of the values in the positive control group. Only an extremely small amount of immature cartilage tissue formed in local regions in the BMSC-only sample, and the scaffold was obviously shrunken and deformed. Although the wet weight of newly generated cartilage tissue in the low-concentration cartilage cell sample reached 30% of the value of the positive control group, the scaffold was obviously shrunken and deformed. Only regional and discontinuous cartilage tissues were formed, and the amount of newly generated cartilage was obviously less than in the co-culture and positive control groups. Conclusions: Cartilage cells can provide a microenvironment for cartilage formation to some extent, and also effectively induce BMSC to differentiate into cartilage cells and form tissue-engineered cartilage in vitro.

Construction of tissue engineered cartilage with Sox9 gene transfection human umbilical cord blood-derived mes-enchymal stem cells and BMG/fibrin

Characterization of Sox9-overexpressing Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells-Based Engineered Cartilage Both in Vitro and in Vivo.

Delivery of the Sox9 Gene Promotes Chondrogenic Differentiation of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells in an in Vitro Model.

Chondrogenic Differentiation of Human Umbilical Cord Mesenchymal Stem Cells Induced by Sox9

In vitro fibrocartilage construction with bone marrow-derived mesenchymal stem cells-fully demineralized bone matrix

The Promotion of Cartilage Defect Repair Using Adenovirus Mediated Sox9 Gene Transfer of Rabbit Bone Marrow Mesenchymal Stem Cells.

Cartilage Tissue Engineering with Demineralized Bone Matrix Gelatin and Fibrin Glue Hybrid Scaffold: an in Vitro Study

Isolated Co-Culture of Bone Mesenchymal Stem Cells and Auricular Chondrocytes to Construct Cartilage

Preliminary Study of in Vitro Cartilage Engineering by BMSCs Induced with TGF-β1,IGF-Ⅰ and Dexamethasone

Chondrogenic Differentiation of Bone Marrow-Derived Mesenchymal Stem Cells Induced by Acellular Cartilage Sheets.

Chondrogenic Differentiation of Umbilical Cord-Derived Mesenchymal Stem Cells in Type I Collagen-Hydrogel for Cartilage Engineering

Effects of Chondrogenic Microenvironment on Construction of Cartilage Tissues Using Marrow Stromal Cells in Vitro.

[Potential of Chondrogenesis of Bone Marrow Stromal Cells Co-Cultured with Chondrocytes on Biodegradable Scaffold: in Vivo Experiment with Pigs and Mice].

Construction of Tissue-Engineered Cartilage with Different Biological Scaffolds in Vitro

The role of Sox9 in collagen hydrogel-mediated chondrogenic differentiation of adult mesenchymal stem cells (MSCs)

Construction of Tissue-Engineered Cartilage by Seeding Chondrocytes on Allogeneic Cancellous Bone Matrix Gelatin

Fabrication of Poly(lactide‐co‐glycolide) Scaffold Filled with Fibrin Gel, Mesenchymal Stem Cells, and Poly(ethylene Oxide)‐b‐poly(l‐lysine)/tgf‐β1 Plasmid DNA Complexes for Cartilage Restoration in Vivo

Reduced hypertrophy in vitro after chondrogenic differentiation of adult human mesenchymal stem cells following adenoviral SOX9 gene delivery

Porcine Fetal Bone Marrow Mesenchymal Stem Cells in Cartilage Tissue Engineering

Novel gene-modified-tissue engineering of cartilage using stable transforming growth factor-β1-transfected mesenchymal stem cells grown on chitosan scaffolds

Non-hypertrophic chondrogenesis of mesenchymal stem cells through mechano-hypoxia programing